Loss of heterozygosity (LOH), malignancy grade and clonality in microdissected prostate cancer

British Journal of Cancer

Volumn 79, Issue 3-4, 1999, Pages 551-557

  Hugel A ^a   Wernert, N ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Loss of heterozygosity; Prostate carcinoma

Indexed keywords

ALLELE; ARTICLE; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; TUMOR BIOPSY; TUMOR GROWTH;

ALLELES; CARCINOMA; DNA, NEOPLASM; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; MALE; PROGNOSIS; PROSTATIC NEOPLASMS; SEVERITY OF ILLNESS INDEX; TUMOR MARKERS, BIOLOGICAL;

EID: 0032903592     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690087     Document Type: Article

References (42)

1. Adams SM, Helps NR, Sharp MGF, Brammar WJ, Walker RA and Varley JM (1992) Isolation and characterization of a novel gene with differential expression in benign and malignant human breast tumors. Hum Mol Genet 1: 91-96
2. Bender B, Wiestler OD and von Deimling A (1994) A device for processing large acrylamide gels. Biotechniques 16: 204-206
3. Böcking A and Sommerkamp H (1980) Histologisches Malignitätsgrading des Prostatakarzinoms. Ver Dtsch Ges Urol 32: 63-65
4. Böcking A, Kiehn J and Heinzel-Wach M (1982) Combined histologie grading of prostatic carcinoma. Cancer 50: 288-294
5. Bookstein R (1994) Tumor suppressor genes in prostatic oncogenesis. J Cell Biochem (suppl.) 19: 217-223
6. Bookstein R, Shew J, Chen P, Scully P and Lee WH (1990) Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated Rb gene. Science 247: 712-715
7. Bookstein R, MacGrogan D, Hilsenbeck SG, Sharkey F and Allred DC (1993) p53 is mutated in a subset of advanced-stage prostate cancers. Cancer Res 53: 3369-3373
8. Buttyan R, Sawczuk IS, Benson MC, Siegal JD and Olsson CA (1987) Enhanced expression of the c-myc protooncogene in high-grade human prostate cancers. Prostate II: 327-337
9. Chi SG, de Vere-White RW, Meyers FJ, Siders DB, Lee F and Gumerlock PH (1994) p53 in prostate cancer: frequent expressed transition mutations. J Natl Cancer Inst 86: 926-933
10. Cleton-Jansen AM, Moerland HW, Callen DF, Dogget NA, Devilee P and Cornelisse CJ (1995) Mapping of the breast basic conserved gene (D16S444E) to human chromosome band 16q24.3. Cytogenet Cell Genet 68: 49-51
11. Cunningham JM, Shan A, Wick MJ, McDonnell SK, Schaid DJ, Tester DJ, Qian J, Takahashi S, Jenkins RB, Bostwick DG and Thibodeau SN (1996) Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Res 56: 4475-4482
12. Dhom G (1991) Pathologie des männlichen Genitale, Tumoren der Prostata. Spezielle Pathologische Anatomie Band 21: 525-642
13. Fleming WH, Hamel A, MacDonald R, Ramsey E, Pettigrew NM, Johnston B, Dodd JG and Matusik RJ (1986) Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia. Cancer Res 46: 1535-1538
14. Gao X, Honn KV, Grignon D, Sakr W and Chen Y-Q (1993) Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostate carcinomas. Cancer Res 53: 2723-2727
15. Gao X, Porter AT and Honn KV (1995a) Tumor suppressor genes and their involvement in human prostate cancer: Review CMB 2: 475-498
16. Gao X, Zacharek A, Grignon D, Liu H, Skr W, Porter AT, Chen YQ and Honn KV (1995b) High frequency of loss of expression and allelic deletion of the APC and MCC genes in human prostate cancer. Int J Oncol 6: 111-117
17. Gao X, Zacharek A, Salkowski A, Grignon DJ, Sakr W, Porter AT and Honn KV (1995c) Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res 55: 1002-1005
18. Gumerlock PH, Poonamallee UR, Mayers FJ and deVere White RW (1991) Activated ras alleles in human carcinoma of the prostate are rare. Cancer Res 51: 1632-1637
19. Hanash KA, Utz DC, Look EN and Taylor WF (1972) Cancer of the prostate: a 15 year follow-up. J Urol 107: 450-453
20. Helpap B. Böcking A, Dhom G, Faul P, Kastendieck H, Leistenschneider W and Müller HA (1985) Klassifikation, histologisches und cytologisches Grading sowie Regressionsgrading des Prostatakarzinoms. Pathologe 6: 3-7
21. Helps NR, Adams SM, Brammar WJ and Varley JM (1995) The Drosophila melanogaster homologue of the human BBC1 gene is highly expressed during embryogenesis. Gene 162: 245-248
22. Isaacs WB (1995) Molecular genetics of prostate cancer. Cancer Surveys 25: 357-379
23. Isaacs WB and Carter BS (1991) Genetic changes associated with prostate cancer in humans. Cancer Surveys 11: 15-53
24. Konishi N, Hiasa Y, Matsuda H, Tao M, Tsuzuki T, Hayashi I, Kitahori Y, Shiraishi T, Yatani R and Shimazaki J (1995) Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma. Am J Pathol 147: 1112-1122
25. Kuhn EJ, Kurnot A, Sesterhenn A, Chan EH and Moul JW (1993) Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma. J Urol 150: 1427-1433
26. Latil A, Fournier G, Cussenot O and Lidereau R (1996) Differential chromosome allelic imbalance in the progression of human prostate cancer. J Urol 156: 2079-2083
27. Lin J, Wu X, Chen J, Chang A and Levine AJ (1994) Functions of the p53 protein in growth regulation and tumor suppression. Cold Spring Harbor Symp Quant Biol 59: 215-223
28. Macdonald F and Ford CHJ (1997) Molecular Biology of Cancer. BIOS Scientific Publishers: Oxford
29. Macoska JA, Trybus TM, Benson PD, Sakr WA, Grignon DJ, Wojno KD, Pietruk T and Powell IJ (1995) Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer. Cancer Res 55: 5390-5395
30. Mirchandani D, Zheng J, Miller GJ, Ghosh AK, Shibata DK, Cote RJ and Roy-Burman P (1995) Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer. Am J Pathol 147: 92-101
31. Moul JW, Friedrichs PA, Lance RS, Theune SM and Chang E (1992) Infrequent RAS oncogene mutations in human prostate cancer. Prostate 20: 327-338
32. Navone NM, Troncoso P, Pisters LL, Goodrow TL, Palmer JL, Nichols WW, von Eschenbach, AC and Conti CJ (1993) p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst 85: 1657-1669
33. Peehl DM (1993) Oncogenes in prostate cancer: an up-date. Cancer (suppl.) 71: 1159-1164
34. Sadasivan R, Morgan R, Jennings S, Austenfeld M, van Veldhuizen P, Stephens R and Noble M (1993) Overexpression of HER-2/NEU may be an indicator of poor prognosis in prostate cancer. J Urol 150: 126-131
35. Sandberg AA (1992) Cytogenetic and molecular genetic aspects of human prostate cancer: primary and metastatic. In Karr JP and Yamanoka H (eds) Prostate Cancer and Bone Metastasis 324: 45-75
36. Trapman J, Sleddens HFBM, van der Weiden MM, Dinjens WNM, Konig JJ, Schroder FH, Faber PW and Bosman FT (1994) Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Cancer Res 54: 6061-6064
37. Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HFM, Schaafsma HE, Debruyne FMJ and Isaacs WB (1992) Expression of the cellular adhesions molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 52: 5104-5109
38. Viola MV, Fromowitz F, Oravez S, Deb S, Finkel G, Lundy J, Hand P, Thor A and Schlom J (1986) Expression of ras oncogene p21 in prostate cancer. N Engl J Med 314: 133-137
39. Vocke CD, Pozzatti RO, Bostwick DG, Florence CD, Jennings SB, Strup SE, Duray PH, Liotta LA, Emmert-Buck R and Linehan WM (1996) Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. Cancer Res 56: 2411-2416
40. von Deimling A, Bender B, Louis DN and Wiestler OD (1993) A rapid and non-radioactive PCR based assay for the detection of allelic loss in human gliomas. Neuropathol Appl Neurobiol 19: 524-529
41. Wales MM, Biel MA, el Deiry W, Nelkin BD, Issa JP, Cavence WK, Kuerbitz SJ and Baylin SB (1995) p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nature Med 1: 570-577
42. Zenklusen JC, Thompson JC, Troncoso P, Kagan J and Cont CJ (1994) Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1. Cancer Res 54: 6370-6373